Skip to main content
. 2020 Jan 23;2(2):57–69. doi: 10.1016/j.sopen.2019.12.005

Table 3.

Summary of Glasgow Royal Infirmary studies

Study Year Patient no. Years incl. Additional incl. & excl. criteria Inflammatory marker Measurement intervals Minimum follow-up
McMillan et al [10] 2003 174 1993–1998 Curative resection of CRC, staged by Dukes CRP Preoperative
4 mo postoperative
Unclear
Canna et al [33] 2005 147 1997–2001 Curative resection of Dukes B or C CRC CRP Preoperative 30 mo
Carruthers et al [38] T3 and T4 borderline or unresectable rectal cancer having preoperative chemoradiotherapy. NLR, PLR, albumin, CEA Preradiotherapy 0.5 mo
Crozier et al [34] 2007 180 1999–2004 Curative resection of CRC. Excludes any emergency cases, preoperative radiotherapy, clinical infection, and inflammatory conditions CRP Preoperative
Day 2 postoperative
22 mo
Crozier et al [35] 2009 188 1999–2006 Curative resection of CRC, preoperative CRP and albumin available mGPS Preoperative 12 mo
Roxburgh et al [12] 2009 287 1997–2004 Curative resection of CRC. Excludes emergency presentation, infection, chronic inflammatory conditions, preoperative radiotherapy GPS Preoperative 34 mo
Proctor et al [36] 2011 27,031 2000–2007 Patients with any cancer, as identified in the Scottish Cancer Registry that had blood tests recorded any time before diagnosis CRP, albumin, white cell count (WCC), neutrophils, LMR, PLR, mGPS, NLR, PI Variable Unclear
Richards et al [37] 2012 343 1997–2007 Stage I–III CRC mGPS Preoperative 45 mo